Stockreport

Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones [Yahoo! Finance]

Virios Therapeutics, Inc.  (VIRI) 
PDF focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), today issued a Shareholder Le [Read more]